Laura Shawver

Laura K.
Shawver is the founder of The Clearity Foundation, founded in 2007, serving as Director since its founding.
Dr. Shawver was the founder of Cleave Therapeutics, Inc., founded in 2011, and served as Chief Executive Officer & Director from 2011 to 2019.
Current jobs included President, Chief Executive Officer & Director at Capstan Therapeutics, Inc. since 2022; Director at Cleave Therapeutics, Inc. since 2019; Independent Director at Bright Peak Therapeutics AG since 2021; Director at Bright Peak Therapeutics, Inc.; Director at ARS Pharmaceuticals, Inc. since 2022; Director at The Clearity Foundation since 2007; and Member at the American Association for Cancer Research.
Former jobs include Chief Executive Officer & Director at Phenomix Corp.
from 2002 to 2010; President, Chief Executive Officer & Director at Synthorx, Inc. from 2017 to 2020; President, Chief Executive Officer & Director at Silverback Therapeutics, Inc. from 2020 to 2022; Director at Antipodean Pharmaceuticals, Inc.; Director at Bird Rock Bio Sub, Inc.; Independent Director at Cornerstone Therapeutics, Inc. from 2012 to 2014; Independent Director at Nkarta, Inc. from 2020 to 2023; Independent Director at Relay Therapeutics, Inc. from 2017 to 2025; President at Sugen, Inc. from 1992 to 2002; and Executive in Residence at 5AM Venture Management LLC from 2010 to 2011.
Education includes a doctorate degree conferred in 1984 and an undergraduate degree conferred in 1979, both from the University of Iowa.